Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS

JAMA Dermatol. 2024 Feb 1;160(2):235-236. doi: 10.1001/jamadermatol.2023.4727.

Authors

Connor R Buechler^{1

2}, Zachary J Anderson³, Sara A Kullberg¹, Daniel D Miller¹, Aileen Ahiskali⁴, Ronald Schut⁵, Sara A Hylwa^{1

6}

Affiliations

¹ Department of Dermatology, University of Minnesota, Minneapolis.
² Department of Internal Medicine, University of Minnesota, Minneapolis.
³ Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
⁴ Department of Pharmacy, Hennepin Healthcare, Minneapolis, Minnesota.
⁵ Department of Infectious Diseases, Hennepin Healthcare, Minneapolis, Minnesota.
⁶ Department of Dermatology, Hennepin Healthcare, Minneapolis, Minnesota.

PMID: 38055229
DOI: 10.1001/jamadermatol.2023.4727

No abstract available

Plain language summary

This case report describes a man in his 50s with HIV/AIDS who presented with widely scattered recalcitrant mpox lesions.

MeSH terms

Acquired Immunodeficiency Syndrome*
Antiviral Agents / therapeutic use
Cidofovir
Cytosine / therapeutic use
Humans
Injections, Intralesional
Mpox (monkeypox)*
Papillomavirus Infections*

Substances

Cidofovir
Antiviral Agents
Cytosine